Belvedere Trading Reduces $2K in Canopy Growth Corporation ($CGC)
Key Points
- Belvedere Trading changed its Canopy Growth Corporation ($CGC) stake by 100.0% last quarter, cutting to 0 shares.
- Wall Street's consensus rating on $CGC is Hold and an average price target of $1.76.
- $CGC last traded around $1.02.
Belvedere Trading reduced its position in Canopy Growth Corporation ($CGC), according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 0 shares of Canopy Growth Corporation after selling 2,155 shares during the quarter.
Canopy Growth Corporation ($CGC) Stock
Canopy Growth Corporation Earnings
Analysts Set New Price Targets
About Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
See Also
This instant news alert was generated by automated narrative technology and financial data from Trueearnings and public regulatory filings. It is for informational purposes only and is not financial advice.